Glucagon-like Peptide Receptor Agonists (GLP-1 receptor agonists): A Powerful Addition to Foundational Therapy Kidney Care in Patients with Type 2 Diabetes Mellitus. Can Diabetes Endocrinol Today [Internet]. 2024 Nov. 25 [cited 2026 Mar. 29];2(3):33–37. Available from: https://CanadianDiabetesAndEndocrinologyToday.com/article/view/2-3-Girard